AzTrials
AzTrials

Pressure UlcerNCT06151769

The Effect Pomegranate Seed Oil Prevention and Progression Pressure Ulcers in Intensive Care Patients

A study testing topical pomegranate seed oil and Sesame oil in people with Pressure Ulcer, run by TC Erciyes University at 2 sites in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Pressure sores are an important health problem that can be seen at any age and in any environment where care is provided, especially in intensive care units. It is a problem that can frequently develop, especially in people who are bedridden for long periods of time and who have acute or chronic diseases. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Pressure Ulcer
What is being tested?
topical pomegranate seed oil and Sesame oil
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
2 sitesTurkey (Türkiye)
Study dates
18 Feb 2024to 15 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Without skin disease
  • Those within the first 24 hours of admission to the intensive care clinic,
  • Those with medium, high and very high risk according to the Braden risk assessment scale
  • Patients without malnutrition according to CONUT score
  • Those with hemoglobin level of 8 and above
  • Patients who will stay in intensive care for 6 days or more
  • Those with a BMI of 35 and below
  • Those whose oxygen saturation is 90 and above

Who cannot join

  • Those who do not allow themselves or their first degree relatives to participate in the study,
  • Those with pressure sores during hospitalization,
  • Those with severe edema (+4 and above),
  • Those with albumin 2 and below
  • Those with prealbumin 10 and below,
  • Those who have a known allergy to any skin care product,
  • Patients with contraindications due to brain death, cardiac arrest, etc.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Handan Topan

    Kayseri, 38039

    Handan Topan, +905057859560, handan_varol@hotmail.com

  • Handan

    Kayseri, 38039

    Handan Topan, +905057859560, handan_varol@hotmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Topical Pomegranate Seed Oil on Prevention and Progression of Control Pressure Ulcers in Intensive Care Patients

Pressure sores are an important health problem that can be seen at any age and in any environment where care is provided, especially in intensive care units. It is a problem that can frequently develop, especially in people who are bedridden for long periods of time and who have acute or chronic diseases. While the incidence of pressure ulcers in hospitals is 10-23%, this rate has been reported to be 8.1%-41% in intensive care units. In Turkey, the incidence of pressure ulcers in patients receiving mechanical ventilation treatment for at least 24 hours was found to be 17% and 15.5% in intensive care units.

It is an important problem that requires long-term care and treatment after the development of a pressure sore, prolongs the duration of hospitalization, has high treatment and care costs, and increases morbidity. In a systematic review, it was stated that pressure ulcer treatment, in addition to normal treatment, increased the per capita cost of care between € 2.65 and € 87.57 per day.The care provided due to developing pressure sores increases the burden on healthcare professionals and makes it difficult to achieve the desired quality of care.It also brings an extra financial burden to care institutions.Studies have found that pressure ulcer development increases the cost of nursing care. Pressure sores also cause pain, infection, etc. in patients. It leads to the development of serious problems, deterioration in comfort and a significant decrease in the quality of life. The use of complementary medicines, including medicinal plants, has long been recommended in this regard.

The latest approaches in medicine recommend its use in the prevention and treatment of diseases due to its fewer side effects, and it is welcomed by patients. Assessment and care of the skin is important in preventing pressure sores. Pomegranate seed oil is very rich in conjugated fatty acids (linoleic and linolenic fatty acids). Although the effectiveness of pomegranate seed oil has been investigated in many subjects, there is no study examining its effectiveness in preventing and healing wound development. The aim of this study is to determine the application of topical pomegranate seed oil. To examine its effect on pressure sore development and progression. To determine the effect of topical pomegranate seed application on the prevention and progression of pressure sores. It will be conducted as a randomized controlled experimental study.

Read the detailed description

Pressure sores are an important health problem that can be seen at any age and in any environment where care is provided, especially in intensive care units. It is a problem that can frequently develop especially in people who are bedridden for long periods of time and have acute or chronic diseases. While the incidence of pressure ulcers in hospitals is 10-23%, this rate has been reported to be 8.1%-41% in intensive care units. In Turkey, the incidence of pressure ulcers in patients receiving mechanical ventilation treatment for at least 24 hours was found to be 17% and 15.5% in intensive care units.

It is an important problem that requires long-term care and treatment after the development of a pressure sore, prolongs the duration of hospitalization, has high treatment and care costs, and increases morbidity. In a systematic review , it was stated that pressure sore treatment, in addition to normal treatment, increased the per capita cost of care between 2.65 € and 87.57 € per day. According to data published in the National Pressure Ulcer Advisory Panel (NPUAP) in 2016, it has been reported that the frequency of pressure ulcers in the United States is between 1.3-3 million and its annual cost is around 2.2-3.6 billion dollars. When the situation in pressure sores in our country is examined, it was determined that the average number of patients with pressure sores annually is 2.5 million and the annual cost of these patients to the country is 11.5 billion dollars.

The care provided due to developing pressure sores increases the burden of healthcare professionals and makes it difficult to achieve the desired quality of care. It also brings an extra financial burden to care institutions. Studies have found that pressure ulcer development increases the cost of nursing care.

Pressure sores also cause pain, infection, etc. in patients. It leads to the development of serious problems, deterioration in comfort and a significant decrease in the quality of life. To prevent all this, in recent years, various initiatives have been undertaken in clinical areas to prevent pressure sores and heal wounds, mainly based on the application of evidence-based guidelines. According to studies, it has been determined that different methods are used for the prevention and healing of pressure sores. In experimental or quasi-experimental studies conducted according to different methods, it was found that the development of pressure sores was not affected and in other studies it was found that it did not provide an effective change in prevalence but reduced the incidence. A study on the prevention of pressure sores, pressure-relieving mattresses and planned repositioning, anodal and cathodal-anodal electrical stimulation in category II-IV pressure sores, chronic The effects of negative pressure vacuum-assisted closure technology on the rapid healing of wounds were examined. Again, such as the effect of laser treatment on angiography, fibrogenic factors and cytokine concentrations during the healing process of pressure sores and stem cell therapy in skin wound healing methods were used. However, no definitive method to treat and prevent pressure sores has been discovered so far.

The use of complementary medicines, including medicinal plants, has long been recommended in this regard. Recent approaches in medicine recommend its use in the prevention and treatment of diseases because it has fewer side effects, and it is welcomed by patients. In a study examining the effect of olive oil on preventing pressure sores in bedridden patients, it was determined that the use of olive oil could be an effective method.

Assessment and care of the skin is important in preventing pressure sores. Dry skin is very effective in the development of pressure sores. In another study, aloe vera gel was applied to patients at risk of developing pressure sores in orthopedic clinics. No symptoms such as increased temperature, redness or swelling were observed in the areas where aloe vera gel was applied. Therefore, it can be applied to prevent pressure sores. Smooth skin is more resistant to external pressures.

Pomegranate seed oil is very rich in conjugated fatty acids (linoleic and linolenic fatty acids). It is reported that pomegranate seed oil is effective in preventing prostate and skin cancer and reducing lipid levels in the liver. Pomegranate seed oil, which has a very high vitamin E content, is also rich in antioxidant polyphenols. In a study conducted with vitamin E, it was found to be effective in oral mucositis preventive and therapeutic oral care practices.

In addition to these effects, pomegranate seed oil is one of the rare products that contain conjugated fatty acids. In a randomized controlled study examining the effect of pomegranate seed oil supplementation on Glucose transporter type 4 (GLUT-4) gene expression and glycemic control in obese people with type 2 diabetes, it was found to significantly increase Glucose transporter type 4 (GLUT-4) gene expression . In a study examining the effect of pomegranate seed oil on serum Tumor necrosis factor (TNF-α) level in dyslipidemic patients, it was found that orally administered pomegranate seed oil did not affect serum Tumor necrosis factor (TNF-α) level in patients with dyslipidemia. In another study examining the effect of pomegranate seed oil on hyperlipidemic subjects, it was found that oral pomegranate seed oil given for 4 weeks had a positive effect on the lipid levels of the patients. As can be seen, although the effectiveness of pomegranate seed oil has been investigated in many subjects in the literature review, there is no study examining its effectiveness in preventing and healing wound development.

The aim of this study is to examine the effect of topical pomegranate seed oil application on pressure ulcer development and progression.

Conditions
Pressure Ulcer
Being tested
topical pomegranate seed oil, Sesame oil
Keywords
Pressure Ulcer, Pomegranate Seed Oil, Intensive Care
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • topical pomegranate seed oilOther

    Intervention groups: In addition to the routine care of the patients, Pomegranate seed oil will be applied to the sacrum and heels twice a day between 09.00-21.00 without pressing. 1.5 cc will be applied to the back of the sacrum and 1 cc to each heel, using circular movements without pressure for approximately 5 seconds. It will be waited for 2-3 minutes for the body to absorb the oil, then it will be touched and removed with a napkin without any rubbing movements. The application will be applied for 6 days. The patient follow-up form will be completed by the researcher every day at 12:00 noon. Again, on the 6th day of the application, evaluation surveys with the Braden risk assessment scale will be conducted by the researcher.

  • Sesame oilOther

    Sesame oil

Study groups in NCT06151769
Study groupRoleWhat they receive
Pomegranate seed oilExperimentalIn addition to the routine care of patients, pomegranate seed oil will be applied to the sacrum and heels twice a day between 09.00-21.00 without pressing. 1.5 cc will be applied to the back of the sacrum and 1 cc to each heel, using circular movements without pressure for approximately 5 seconds. It will be waited for 2-3 minutes for the body to absorb the oil, then it will be touched and removed with a napkin without any rubbing movements. The application will be applied for 6 days.
Receives: Other: topical pomegranate seed oil
Sesame oilActive comparatorIn addition to the routine care of patients, Sesame oil will be applied to the sacrum and heels twice a day between 09.00-21.00 without pressing. 1.5 cc will be applied to the back of the sacrum and 1 cc to each heel, using circular movements without pressure for approximately 5 seconds. It will be waited for 2-3 minutes for the body to absorb the oil, then it will be touched and removed with a napkin without any rubbing movements. The application will be applied for 6 days.
Receives: Other: Sesame oil
Control groupNo interventionPatients will not be interfered with in their routine care. Patient monitoring will be done every afternoon for 6 days.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nutritional Status Control (CONUT score)

    Parameters Normal Light Moderate Severe Serum albümin (g/dl) ≥3.5 3.0-3.49 2.5-2.9 <2.5 Score 0 2 4 6 Total lymphocyte (count/mm3) ≥1600 1200-1599 800-1199 <100 Score 0 1 2 3 Total cholesterol (mg/dl) ≥180 140-180 100-139 <100 Score 0 1 2 3 CONUT score 0-1 2-4 5-8 9-12 Assessment

    Measured: first 1 day

  2. Braden Risk Assessment Scale

    These risk factors are evaluated by nurses and given a score between 6-23. The Braden pressure sore risk assessment scale measures the risk of pressure sores based on total scoring. 6-9 points: Very high risk, 10-12 points: High risk, 13-14 points: Medium risk

    Measured: six days

  3. Ramsay Sedation Scale

    1. Awake and anxious, agitated or restless
    2. Awake, cooperative, accepting ventilation, oriented, calm
    3. Awake, only responding to commands
    4. Sleepy, has a lively/energetic response to light glabellar tapping or loud noise
    5. Sleepy, has a dull/sluggish response to light glabellar tapping or loud noise, but no response to painful sleep
    6. Sleepy, no response to light glabellar beat or loud sound

    Measured: First 1 day

  4. Patient Follow-up Form

    It was created to record the skin evaluation of patients in the intervention and control groups before daily care, and to record blood pressure, respiratory rate, pulse, fever and saturation parameters before the application. Since blood values are checked every day in the intensive care unit, no extra blood will be taken.

    Measured: six days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2023
  2. Study start18 Feb 2024 (estimated)
  3. Primary completion1 Aug 2024 (estimated)
  4. Study completion15 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pomegranate seed oil: Pomegranate seed oil will be applied to the sacrum and heels twice a day between 09.00-21.00 without pressing. This process will continue for six days. Sesame oil: Sesame oil will be applied to the sacrum and heels twice a day between 09.00-21.00 without pressing. This process will continue for six days.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06151769
Sponsor's protocol ID
ErciyesUnı23
Status last verified
Feb 2024
First submitted
14 Nov 2023
Last updated
20 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing topical pomegranate seed oil and Sesame oil in people with Pressure Ulcer, run by TC Erciyes University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nutritional Status Control (CONUT score) (time frame: first 1 day). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in